PLRZ
Polyrizon Ltd. Ordinary SharesNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$24.13M
P/E Ratio
—
EPS
$-4.90
Beta
—
52W High
$18.20
52W Low
$2.88
50-Day MA
$13.77
200-Day MA
$10.68
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Polyrizon Ltd. Ordinary Shares
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company is headquartered in Ra'anana, Israel.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-5.91M |
| Operating Margin | 0.00% |
| Return on Equity | -25.40% |
| Return on Assets | -28.90% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $13.05 |
| Price-to-Book | 1.17 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $2.08M |
| Float | $1.43M |
| % Insiders | 0.82% |
| % Institutions | 8.31% |
Historical Volatility
HV 10-Day
74.80%
HV 20-Day
107.08%
HV 30-Day
103.09%
HV 60-Day
99.68%
HV Rank
—
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 6/13/2026